S-MOXY EYE DROPS Clinical Monograph & Batch COA
Certified DCGI Formulation Literature (PDF)
S-MOXY EYE DROPS
Moxifloxacin HCL 0.5% w/v
S-MOXY EYE DROPS (Moxifloxacin HCL 0.5% w/v) is manufactured under strict WHO-GMP compliance for maximum bioavailability and therapeutic efficacy.
Clinical Pharmacology & Therapeutic Profile
Comprehensive therapeutic guidelines for medical practitioners and institutional procurement
Therapeutic Indications
Mechanism of Action (MOA)
The active pharmacological principles in S-MOXY EYE DROPS deliver targeted therapeutic action through standardized systemic bioavailability and verified pharmacodynamics.
As directed by the registered medical practitioner. Strictly adhere to full course duration.
Well tolerated under clinical supervision. Contraindicated in patients with hypersensitivity to active ingredients.
Store in a cool and dry place. Use within 1 month after opening container.
WHO-GMP Certified Purity
Manufactured in state-of-the-art HVAC controlled cleanrooms with 100% active ingredient bio-potency and analytical batch testing.
Alu-Alu Moisture Barrier
Superior barrier protection against tropical humidity, preventing physical degradation and guaranteeing 24-month stability.
Exclusive District Monopoly
Strict PCD franchise monopoly allocation ensuring zero price competition and complete territory protection for our partners.
Technical Product Specifications
Active Medical Composition
S-MOXY EYE DROPS features Moxifloxacin HCL 0.5% w/v prepared to high pharmaceutical purity standards.
*Disclaimer: Formulations are intended solely for distribution to licensed practitioners, hospitals, and pharmacies. Dosage must adhere to medical advice.
Apply for Exclusive Marketing Rights of S-MOXY EYE DROPS
Check vacant territory availability in your state or district. Enjoy full marketing kit support, visual aids, and guaranteed zero competitor supply.
Questions Regarding S-MOXY EYE DROPS
What is the therapeutic indication and composition of S-MOXY EYE DROPS?
S-MOXY EYE DROPS contains Moxifloxacin HCL 0.5% w/v indicated for Indicated for therapeutic management within specified clinical indications under qualified physician guidance. as formulated by Sygnus Biotech.
What packaging presentations are available for S-MOXY EYE DROPS?
S-MOXY EYE DROPS is supplied in tamper-evident 5ml / 10ml Precision Dropper Bottle with Tamper Ring, engineered with barrier foil protection to ensure a 24 to 36 month shelf life.
Is monopoly PCD franchise territory available for S-MOXY EYE DROPS?
Yes, Sygnus Biotech grants exclusive district-wise monopoly marketing rights for S-MOXY EYE DROPS along with promotional visual aids, product cards, and marketing support.
What is the regulatory schedule and minimum order quantity (MOQ)?
S-MOXY EYE DROPS is categorized as Schedule H with an introductory PCD franchise MOQ of 100 units per batch.
Related Formulations in Drops
View all Drops →
SBFLOX EYE/EAR DROPS
Ofloxacin IP 0.03%w/v + Benzalkonium IP 0.02%v/v
SBSPAS DROPS
An Ayurvedic Digestive Enzymes & Anti Spasmodic Drops
OTINUS-X NASAL DROPS
Xylometazoline IP 0.1% w/v
OTINUS-S NASAL DROPS
Sodium Chloride 0.65% w/v + Benzalkonium Chloride Solution 0.02% v/v